Photo from wikipedia
Somapacitan is a long‐acting, reversible albumin‐binding growth hormone (GH) derivative in development. This study aimed to evaluate the safety and efficacy of once‐weekly somapacitan versus daily GH over 52 weeks… Click to show full abstract
Somapacitan is a long‐acting, reversible albumin‐binding growth hormone (GH) derivative in development. This study aimed to evaluate the safety and efficacy of once‐weekly somapacitan versus daily GH over 52 weeks in Japanese patients with adult growth hormone deficiency (AGHD).
Keywords:
weekly somapacitan;
safety efficacy;
growth hormone;
hormone deficiency;
growth
Journal Title: Clinical Endocrinology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical Endocrinology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!